Additionally, we evaluated the impact of representative residues involved in the IFNγ pathway on surface PD-L1 expression in additional human cancer cell lines, including the melanoma cell line A875, the sarcoma cell line HT1080, and the breast cancer cell line MCF-7, all of which were engineered to stably express ABEmax protein. The gene discussed is IFNG; the disease is sarcoma.